Skip to content

Predicting COVID-19 Patients' Clinical Outcomes Using ICU Mobility Scale and MRC Sum Score

Predicting COVID-19 Patients' Barthel Index and Hospitalization Using ICU Mobility Scale and Medical Research Council Sum Score

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05195736
Enrollment
33
Registered
2022-01-19
Start date
2021-09-16
Completion date
2021-12-31
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

COVID-19, Activities of Daily Living, Muscle Strength

Brief summary

The investigators hypothesize that early mobility condition and muscle power may be the predictive factors for Coronavirus disease 2019(COVID-19) patients' activity prognosis and hospitalization days. To prove our hypothesis, the investigators proposed a retrospective cohort study to see if ICU mobility scale(ICUMS) and Medical Research Council Sum Score(MRCSS) can predicted the patients' Barthel index after discharge and hospitalization days.

Detailed description

The investigators hypothesize that early mobility condition and muscle power may be the predictive factors for COVID-19 patients' activity prognosis and hospitalization days. To prove our hypothesis, the investigators checked the patient's baseline ICUMS and MRCSS upon admission. Also, blood test results were also obtained. Subsequently, the investigators measured their outcomes by Barthel index and hospitalization length, and divided them into two groups. The ICUMS, MRCSS and the blood test results differences between two groups were checked. For those factors that showed significant difference between two groups, the investigators recruited them into regression model. Last, receiver operating curve of those factors were plotted to find the appropriate cutoff points for identifying two groups of outcomes.

Interventions

None listed

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* COVID-19 patients diagnosed by positive polymerase chain reaction(PCR)

Exclusion criteria

* Impaired baseline activities, such as stroke, fracture, neurodegenerative disease * Baseline Barthel index score less than 100 * Lost follow-up

Design outcomes

Primary

MeasureTime frameDescription
Barthel indexBarthel index score 3 months after dischargeScore from 0 to100. Higher score indicates better daily activities of living.
Hospitalization daysdaysHospitalization days

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026